OverviewSuggest Edit

Bayer is a global life science company specializing in healthcare and nutrition. The company operates in three segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment engages in the development, production, and marketing of seeds, plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health, specialty therapeutics in the areas of oncology, hematology, and ophthalmology, as well as diagnostic imaging equipment and contrast agents. The Consumer Health segment offers nonprescription over-the-counter medicines, medical products, cosmetics, and other self-care solutions in the categories of dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cough and cold.

TypePublic
Founded1863
HQLeverkusen, DE
Websitebayer.com
Overall CultureD

Latest Updates

Employees (est.) (Jun 2020)101,168(-2%)
Job Openings1,913
Revenue (FY, 2019)€43.5 B(+11%)
Share Price (Jul 2021)€51.2(+2%)

Key People/Management at Bayer

Werner Baumann

Werner Baumann

Chairman of the Board of Management, CEO
Liam Condon

Liam Condon

Member of the Board of Management, Crop Science
Rodrigo Santos

Rodrigo Santos

Chief Operating Officer, Crop Science
Wolfgang Nickl

Wolfgang Nickl

Member of the Board of Management, Finance
Stefan Oelrich

Stefan Oelrich

Member of the Board of Management, Pharmaceuticals
Heiko Schipper

Heiko Schipper

Member of the Board of Management, Consumer Health
Show more

Bayer Office Locations

Bayer has offices in Leverkusen, Bergkamen, Berlin, Bitterfeld-Wolfen and in 103 other locations
Leverkusen, DE (HQ)
Kaiser-Wilhelm-Allee 1
Bergkamen, DE
Ernst-Schering-Straße 14
Berlin, DE
Müllerstraße 7
Bitterfeld-Wolfen, DE
Salegaster Chaussee 1
Burscheid, DE
Sträßchen 30
Frankfurt am Main, DE
Brüningstraße 50
Show all (109)

Bayer Financials and Metrics

Bayer Revenue

Embed Graph
View revenue for all periods
Bayer's revenue was reported to be €43.55 b in FY, 2019 which is a 10% increase from the previous period.
EUR

Revenue (Q3, 2020)

8.5b

Gross profit (Q3, 2020)

1.7b

Gross profit margin (Q3, 2020), %

20.1%

Net income (Q3, 2020)

(7.7b)

EBIT (Q3, 2020)

(9.4b)

Market capitalization (29-Jul-2021)

50.0b

Closing stock price (29-Jul-2021)

51.2

Cash (30-Sept-2020)

5.1b

EV

88.4b
Bayer's current market capitalization is €50 b.
Annual
EURFY, 2017FY, 2018FY, 2019

Revenue

35.0b39.6b43.5b

Revenue growth, %

(25%)13%10%

Cost of goods sold

11.4b17.0b17.5b

Gross profit

23.6b22.6b26.1b
Quarterly
EURQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Revenue

9.1b9.5b9.9b13.0b11.5b9.8b12.8b10.1b8.5b

Cost of goods sold

2.9b3.5b4.5b5.3b4.4b3.7b4.7b4.0b6.8b

Gross profit

6.2b6.0b5.4b7.8b7.1b6.1b8.2b6.0b1.7b

Gross profit Margin, %

68%63%54%60%62%62%64%60%20%
Annual
EURFY, 2017FY, 2018FY, 2019

Cash

7.6b4.1b3.2b

Accounts Receivable

8.6b11.8b11.7b

Inventories

6.6b11.0b10.8b

Current Assets

30.1b30.9b32.6b
Quarterly
EURQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Cash

5.3b5.0b4.9b4.1b3.3b4.4b2.3b3.1b5.1b

Accounts Receivable

9.5b14.3b11.7b14.3b14.2b11.9b14.3b13.1b10.2b

Inventories

6.4b11.1b11.1b10.7b10.4b10.5b10.0b10.1b10.5b

Current Assets

33.2b37.8b32.1b32.7b32.8b33.5b33.0b32.8b39.3b
Annual
EURFY, 2017FY, 2018FY, 2019

Net Income

7.3b1.7b2.4b

Depreciation and Amortization

2.7b6.4b5.4b

Inventories

(293.0m)615.0m(103.0m)

Accounts Payable

265.0m(44.0m)759.0m
Quarterly
EURQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Net Income

2.0b2.8b5.6b1.2b1.6b2.6b1.4b(8.2b)(15.9b)

Depreciation and Amortization

508.0m1.2b2.1b1.2b2.7b3.8b1.3b2.5b12.8b

Inventories

(84.0m)183.0m219.0m456.0m588.0m296.0m396.0m219.0m(264.0m)

Accounts Payable

(436.0m)(542.0m)(102.0m)17.0m(438.0m)(18.0m)(1.1b)(1.3b)(697.0m)
EURFY, 2017

EV/EBIT

17.7 x

EV/CFO

12.8 x

Revenue/Employee

350.8k

Debt/Equity

0.4 x

Debt/Assets

0.2 x

Financial Leverage

2 x

P/E Ratio

13.3
Show all financial metrics

Bayer Operating Metrics

FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Countries

147151152148153

Suppliers

112 k112.5 k110.9 k93.33 k101.19 k86.4 k

Patent Applications

68.2 k66.7 k50.8 k48.1 k

Patents Issued

8.3 k7.2 k5 k4.7 k
Show all operating metrics

Bayer Acquisitions / Subsidiaries

Company NameDateDeal Size
Asklepios BioPharmaceuticalOctober 26, 2020$2 b
Care/ofAugust 31, 2020$225 m
KaNDy TherapeuticsAugust 14, 2020$450 m
BlueRock TherapeuticsAugust 08, 2019$1 b
Monsanto CompanyMay 23, 2016$62.5 b
Zoner.agFebruary 15, 2015
Dihon PharmaceuticalNovember 05, 2014€460 m
Merck-Consumer Care (MCC)October 01, 2014$14.2 b
AlgetaDecember 19, 2013$2.9 b
AgraQuest, Inc.July 01, 2012$425 m
Show more

Bayer Revenue Breakdown

Embed Graph

Bayer revenue breakdown by business segment: 12.5% from Consumer Health, 41.2% from Pharmaceuticals, 45.5% from CropScience and 0.7% from Other

Bayer revenue breakdown by geographic segment: 15.3% from Latin America, 19.8% from Asia / Pacific, 34.6% from North America and 30.3% from Europe / Middle East / Africa

Human Capital Metrics

Bayer's employees are reported to be approximately 40% female and 60% male.
Embed Graph
Show all human capital metrics

Bayer Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

50-59

out of 100

CSRHub logo

Bayer Online and Social Media Presence

Embed Graph

Bayer Company Culture

  • Overall Culture

    D

    59/100

  • CEO Rating

    D

    64/100

  • Compensation

    B-

    74/100

Learn more on Comparably

Bayer News and Updates

Enko, Bayer Collaborate on New Chemistries for Safe Pesticides

MYSTIC, Conn., July 27, 2021 /PRNewswire/ -- Enko, the crop health company, announced details on its partnership with Bayer to develop diverse chemistries for crop protection. Applying drug discovery approaches from pharma to crop protection will allow the companies to identify unexpected...

Worldwide Disposable Medical Supplies Industry to 2030 - Featuring 3M, Baxter International and Bayer Among Others

Dublin, July 22, 2021 (GLOBE NEWSWIRE) -- The "Global Disposable Medical Supplies Market 2020-2030 by Product Type, Raw Material, Application, End User, and Region: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering. The global disposable medical supp…

Worldwide Anticoagulants Industry to 2026 - Featuring Aspen Holdings, Bayer and Pfizer Among Others

Dublin, July 07, 2021 (GLOBE NEWSWIRE) -- The "Global Anticoagulants Market (2021-2026) by Drug Class, Route of Administration, Geography and the Impact of COVID-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

Global Foot Insoles Market (2021 to 2025) - Featuring Aetrex Worldwide, Bayer and Implus Footcare Among Others

Dublin, July 05, 2021 (GLOBE NEWSWIRE) -- The "Global Foot Insoles Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. The publisher has been monitoring the foot insoles market and it is poised to grow by $1.41 billion during 2021-2025, progressing at a CAGR of almost 8% …

Global Kinase Inhibitors Market Report 2021-2026Featuring Major Players - Pfizer, Novartis, AstraZeneca, Bayer, Eisai and Johnson & Johnson

Dublin, July 02, 2021 (GLOBE NEWSWIRE) -- The "Global Kinase Inhibitors Market 2021-2026" report has been added to ResearchAndMarkets.com's offering.

China Moxifloxacin Market Research Report 2021: A Fourth-generation Synthetic Quinolone Antibacterial Drug (8-methoxy-fluoroquinolone Antibiotic) Developed by Bayer Vital

Dublin, July 02, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Moxifloxacin Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. Moxifloxacin is a fourth-generation synthetic quinolone antibacterial drug (8-methoxy-fluoroquinolone antibiotic) developed by B…
Show more

Bayer Blogs

Show more

Bayer Frequently Asked Questions

  • When was Bayer founded?

    Bayer was founded in 1863.

  • Who are Bayer key executives?

    Bayer's key executives are Werner Baumann, Liam Condon and Rodrigo Santos.

  • How many employees does Bayer have?

    Bayer has 101,168 employees.

  • What is Bayer revenue?

    Latest Bayer annual revenue is €43.5 b.

  • What is Bayer revenue per employee?

    Latest Bayer revenue per employee is €430.4 k.

  • Who are Bayer competitors?

    Competitors of Bayer include Shionogi, Daiichi Sankyo and Astellas Pharma.

  • Where is Bayer headquarters?

    Bayer headquarters is located at Kaiser-Wilhelm-Allee 1, Leverkusen.

  • Where are Bayer offices?

    Bayer has offices in Leverkusen, Bergkamen, Berlin, Bitterfeld-Wolfen and in 103 other locations.

  • How many offices does Bayer have?

    Bayer has 109 offices.